Phase 2 Breast Cancer Brain Metastases Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 2

Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases.

Breast Cancer Brain Metastases

Shanghai Pharmaceuticals Holding Co., Ltd52 enrolled25 locationsNCT05872347

Recruiting

Phase 1Phase 2

Study of SHR-A1811 Combined With Pyrotinib and Bevacizumab in Advanced Breast Cancer With Brain Metastasis

Breast Cancer MetastaticBreast Cancer Brain Metastases

Fudan University74 enrolled1 locationNCT06718933

Recruiting

Phase 2

Adebrelimab Plus Apatinib and Etoposide for the Treatment of HER2-Negative Breast Cancer Brain Metastasis

HER2-negative Breast Cancer Brain Metastases

Beijing 302 Hospital30 enrolled1 locationNCT06418594